Respiratory exercise in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 13, Issue 1, 2012, Pages 33-43

  Pinto, Susana ^a   Swash, Michael ^a,b   De Carvalho, Mamede ^a,c  

^a INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Amyotrophic lateral sclerosis; Delayed start design; Inspiratory muscle training

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ARTICLE; BREATHING EXERCISE; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; INSPIRATORY CAPACITY; LUNG FUNCTION TEST; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; NEUROPHYSIOLOGY; PEAK EXPIRATORY FLOW; PLACEBO EFFECT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SNIFF INSPIRATORY PRESSURE; TREATMENT DURATION;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATION; RESPIRATORY FUNCTION TESTS; RESPIRATORY THERAPY; TREATMENT OUTCOME;

EID: 84855393960     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2011.626052     Document Type: Article

References (59)

1. Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tarnop-olsky MA. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve. 2004;29:656-62. (Pubitemid 38620006)
2. Bruestle DA, Cutler RG, Telljohann RS, Mattson MP. Decline in daily running distance presages disease onset in a mouse model of ALS. Neuromolecular Med. 2009;11:58-62.
3. Kirkinezos IG, Hernandez D, Bradley GW, Moraes CT. Regular exercise is beneficial to a mouse model of amyo-trophic lateral sclerosis. Ann Neurol. 2003;53:804-7. (Pubitemid 36622520)
4. Deforges S, Branchu J, Biondi O, Grondard C, Pariset C, L é colle S, et al. Motor neuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol. 2009;587:3561-72.
5. Pinto AC, Alves M, Nogueira A, Evangelista T, Carvalho J, Coelho A, et al. Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J Neurol Sci. 1995;169:69-75.
6. Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001;191:133-7. (Pubitemid 33035906)
7. Bello-Haas VD, Florence JM, Kloos AD, Scheirbecker J, Lopate G, Hayes SM, et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology. 2007;68:2003-7. (Pubitemid 46869704)
8. Einarsson G. Muscle conditioning in late poliolyelitis. Arch Phys Med Rehabil. 1991;72:11-4.
9. de Carvalho M, Matias T, Evangelista T, Pinto A, Sales Lu í s ML. Motor neuron disease presenting with respiratory failure. J Neurol Sci. 1996;139:117-22.
10. Pinto S, Geraldes R, Vaz N, Pinto A, de Carvalho M. Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis: longitudinal study. Clin Neurophysiol. 2009;120: 2082-5.
11. de Carvalho M, Pinto S, Swash M. Association of paraspinal and diaphragm denervation in ALS. Amyotroph Lateral Scler. 2009;15:1-4.
12. Rochester DF, Arora NS, Braun NMT, Goldberg SK. The respiratory muscles in chronic obstructive pulmonary disease (COPD). Bull Eur Physiopathol Respir. 1979;15: 951-75. (Pubitemid 10237789)
13. Clanton TL, Dixon G, Drake J, Gadek GE. Inspiratory muscle conditioning using a threshold loading device. Chest. 1985;87:62-6. (Pubitemid 15131399)
14. Goldstein RS, de Rosie J, Long S, Dolmage T, Avendano MA. Applicability of a threshold loading device for inspira-tory muscle testing and training in patients with COPD. Chest. 1989;96:564-71. (Pubitemid 19230378)
15. Roussos CS, Macklem PT. Diaphragmatic fatigue in man. J Appl Physiol. 1977;43:189-97. (Pubitemid 8172687)
16. Bellemare F, Grassino A. Effect of pressure and timing of contraction on human diaphragm fatigue. J Appl Physiol. 1982;53:1190-5. (Pubitemid 13220605)
17. Larson JL, Kim MJ, Sharp JT, Larson DA. Inspiratory muscle training with a pressure threshold breathing device in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1988;138:689-96.
18. Weiner P, Azgad Y, Ganam R, Weiner M. Inspiratory muscle training in patients with bronchial asthma. Chest. 1992;102:1357-61.
19. Enright S, Chatham K, Ionescu AA, Untan VB, Shale DJ. Inspiratory muscle training improves lung function and exercise capacity in adults with cystic fibrosis. Chest. 2004;126:405-11. (Pubitemid 39093424)
20. Fregonezi GA, Resqueti VR, Guell R, Pradas J, Casan P. Effects of eight-week, interval-based inspiratory muscle training and breathing retraining in patients with generalized myasthaenia gravis. Chest. 2005;128:1524-30. (Pubitemid 41324442)
21. Koessler W, Wanke T, Winkler G, Nader A, ToiflK, Kurz H, Zwick H. Two years experience with inspiratory muscle training in patients with neuromuscular disorders. Chest. 2001;120:765-9. (Pubitemid 32885447)
22. Gozal D, Thiriet P. Respiratory muscle training in neu-romuscular disease: long-term effects on strength and load perception. Med Sci Sports Exerc. 1999;31: 1522-7.
23. Martin AD, Davenport PD, Franceschi AC, Harman E. Use of inspiratory muscle strength training to facilitate ventilator weaning: a series of 10 consecutive patients. Chest. 2002; 122:192-6. (Pubitemid 34754161)
24. Brooks BR, Miller RG, Swash M, Munsat TL, for the World Federation of Neurology Research Committee on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2000;1:293-300.
25. Cedarbaum JM, Stambler N. Performance of the Amyo-trophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicentre clinical trials. J Neurol Sci. 1997; 152(Suppl):S1-9. (Pubitemid 27505283)
26. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13-21. (Pubitemid 29502501)
27. American Thoracic Society. Standardization of spirometry. Am J Respir Crit Care Med. 1995;152:1107-36.
28. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report of working party standardization of lung function tests. European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J. 1993;16(Suppl):5-40.
29. Whitelaw WA, Derenne JP, Milic-Emili J. Occlusion pressure as a measure of respiratory centre output in conscious man. Resp Physiol. 1975;23:181-99.
30. Lavietes MH, Clifford E, Silverstein D, Stier F, Reichman LB. Relationship of static respiratory muscle pressure and maximum voluntary ventilation in normal subjects. Respiration. 1979;38:121-6. (Pubitemid 10197058)
31. Fitting JW, Paillex R, Hirt L, Aebischer P, Schluep M. Sniff nasal pressure. A sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol. 1999;46:887-93.
32. de Carvalho M, Costa J, Pinto S, Pinto A. Percutaneous nocturnal oximetry in amyotrophic lateral sclerosis: periodic desaturation. Amyotroph Lateral Scler. 2009;10:154-61.
33. Pinto S, Turkman A, Pinto A, Swash M, de Carvalho M. Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies. Clin Neurophys-iol. 2009;120:2082-5.
34. Pinto S, de Carvalho M. Symmetry of phrenic nerve motor response in amyotrophic lateral sclerosis. Muscle Nerve. 2010;42:882.
35. de Carvalho M, Scotto M, Lopes A, Swash M. Quantitating progression in ALS. Neurology. 2005;64:1783-5. (Pubitemid 40695819)
36. Swash M, de Carvalho M. The neurophysiological index in ALS. Amyotroph Lateral Scler. 2004; (Suppl 1):108-10. (Pubitemid 39406547)
37. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121-3. (Pubitemid 19246303)
38. Mahler DA, Horowitz MB. Clinical evaluation of exertional dyspnoea. Clin Chest Med. 1994;15:259-69.
39. Hamilton M. A rating scale for depression. J Neurol Neuro-surg Psychiatry. 1960;23:56-62.
40. Johns MW. A New Method For Measuring Daytime Sleepiness: The Epworth Sleepiness Scale. Sleep. 1991;14:540-5.
41. Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6-18.
42. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337-43. (Pubitemid 32675374)
43. Fallat RJ, Norris FH, Holden D, Kandal K, Roggero PC. Respiratory monitoring and treatment: objective treatments using non-invasive measurements. Adv Exp Med Biol. 1987;209:191-200.
44. Gross D, Meiner Z. The effect of ventilatory muscle training on respiratory function and capacity in ambulatory and bedridden patients with neuromuscular disease. Monaldi Arch Chest Dis. 1993;48:322-6. (Pubitemid 23334609)
45. Schiffman PL, Belsh JM. Effect of inspiratory resistance and theophylline on respiratory muscle strength in patients with amyotrophic lateral sclerosis. Am Rev Respir Dis. 1989;139:1418-23. (Pubitemid 19155500)
46. Nardin R, O'Donnell C, Loring SH, Nie R, Hembre K, Walsh J, et al. Diaphragm training in amyotrophic lateral sclerosis. J Clin Neuromuscul Dis. 2008;10:56-60.
47. Cheah BC, Boland RA, Brodaty NA, Zoing MG, Jeffery SE, McKenzie DK, Kiernan MC. INSPIRATIonAL-INSPIR-Atory muscle Training In Amyotrophic Lateral sclerosis. Amyotroph Lateral Scler. 2009;10:384-92.
48. Bennett RL, Knowlton GC. Overwork weakness in partially denervated skeletal muscle. Clin Orthop. 1958;12:711-5.
49. Tam SL, Archibald V, Tyreman N, Gordon T. Effect of exercise on stability of chronically enlarged motor units. Muscle Nerve. 2002;25:359-69. (Pubitemid 34203212)
50. Larson M, Kim MJ. Respiratory muscle training with the incentive spirometer resistive breathing device. Heart Lung. 1984;13:341-5. (Pubitemid 14090803)
51. Parkinson Study Group. A controlled, randomized, delayed-start study of rasagiline in early Parkinson's disease. Arch Neurol. 2004;61:561-6.
52. Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, et al., ADAGIO study investigators. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med. 2009;361:1268-78.
53. Kaufmann P, Levy G, Thompson JLP, del Bene ML, Battista V, Gordon PH, et al. The ALSFRS-R predicts survival time in an ALS clinic population. Neurology. 2005;64:38-43. (Pubitemid 40082934)
54. Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in als. Neurology. 2006;66:265-7. (Pubitemid 43970171)
55. Gordon PH, Cheung YK. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;67:1314-5.
56. Czaplinski A, Ye n AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry. 2006;77:390-2.
57. Schmidt EP, Drachman DB, Wiener CM, Clawson L, Kimball R, Lechtzin N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve. 2006;33:127-32. (Pubitemid 43062995)
58. Baumann F, Henderson RD, Morrison SC, Brown M, Hutchinson N, Douglas JA, et al. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11: 194-202.
59. Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171:269-74.